Works matching IS 11782595 AND DT 2012 AND VI 26 AND IP 3
Results: 8
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 213, doi. 10.1007/BF03262395
- Publication type:
- Article
Journal Watch.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 201, doi. 10.1007/BF03262394
- By:
- Publication type:
- Article
Forum.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 189, doi. 10.1007/BF03262393
- Publication type:
- Article
Phase III Trial of Eprotirome.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 185, doi. 10.1007/BF03262392
- By:
- Publication type:
- Article
Drugs in Clinical Development for Melanoma.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 172, doi. 10.1007/BF03262391
- Publication type:
- Article
An Analysis of Guidance for Proper Usage Document for Oncology Drugs in Japan.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 165, doi. 10.1007/BF03262390
- By:
- Publication type:
- Article
Pharmacovigilance Regulatory Requirements in Latin America.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 153, doi. 10.1007/BF03262389
- By:
- Publication type:
- Article
The US Biosimilars Act Challenges Facing Regulatory Approval.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 145, doi. 10.1007/BF03262388
- By:
- Publication type:
- Article